Alyeska Investment Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-20,601
Closed -$1.09M 325
2013
Q2
$1.09M Buy
+20,601
New +$1.09M 0.05% 199